Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer minor version of the documentation. This reflects a small update to the page metadata rather than substantive content changes.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRecruitment is now closed for this study, as indicated by 'No longer looking for participants.' The page also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the labeling of the Intervention/Treatment section along with a Revision: v3.6.0.SummaryDifference0.3%

- Check23 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, reflecting a small update to the page's documentation/version metadata.SummaryDifference0.0%

- Check45 days agoChange DetectedA new revision tag 'Revision: v3.5.4' appears, replacing the previous 'Revision: v3.5.3'. This indicates a minor update to the page's record rather than a substantive change to the study details.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page’s displayed software/document revision identifier was updated from v3.5.2 to v3.5.3 without changing the underlying study information.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.